Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRICHLORMETHIAZIDE vs TRILACICLIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TRICHLORMETHIAZIDE vs TRILACICLIB: Safety Overview

Metric TRICHLORMETHIAZIDE TRILACICLIB
Total FAERS Reports 342 226
Deaths Reported 24 29
Death Rate 7.0% 12.8%
Hospitalizations 240 96
Average Patient Age 75.9 yrs 62.2 yrs
% Female Patients 66.0% 43.9%
FDA Approval Date Approved Prior to Jan 1, 1982 Feb 12, 2021
Manufacturer N/A Pharmacosmos Therapeutics Inc.
Route N/A INTRAVENOUS
Marketing Status Discontinued Prescription